Skip to main content
Top
Published in: BMC Infectious Diseases 1/2021

Open Access 01-12-2021 | Lymphoma | Research article

A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection

Authors: Jingjing Li, Ming Xue, Shuo Yan, Chunshuang Guan, Ruming Xie, Budong Chen

Published in: BMC Infectious Diseases | Issue 1/2021

Login to get access

Abstract

Background

Patients with acquired immune deficiency syndrome (AIDS) often suffer from opportunistic infections and related primary central nervous system lymphoma (AR-PCNSL). Both diseases showed multiple ring enhancement lesions in conventional magnetic resonance (MR). It is very difficult to make the differential diagnosis. We aimed to investigate whether multimodal MR (diffusion weighted imaging (DWI)/ apparent diffusion coefficient (ADC), 3D pseudo-continuous arterial spin labeling (3D-pCASL) and susceptibility-weighted imaging (SWI)) combined with conventional MR can differentiate AR-PCNSL from infections.

Methods

This was a prospective study. We recruited 19 AIDS patients who were divided into AR-PCNSL group (9 cases) and infection group (10 cases) by pathological results. We analyzed whether there was statistical (Fisher’s method) difference in multimodal MR between the two groups. We analyzed whether multimodal MR combined with conventional MR could improve the diagnosis of AR-PCNSL.

Results

The lesions were more likely involved the paraventricular (0.020) and corpus callosum (0.033) in AR-PCNSL group in conventional MR. In multimodal MR, AR-PCNSL group showed low ADC value, with p values of 0.001. Infection group more inclined to high ADC value, with p was 0.003. In multimodal MR, AR-PCNSL group had more low signal intensity (grade 2–3) in the degree of intratumoral susceptibility signal intensity in SWI (SWI-ITSS), with p values of 0.001. The sensitivity, specificity of conventional MR in the diagnosis of AR-PCNSL was 88.9 and 70.0%. The conventional MR sequence combined with DWI/ADC sequence in the diagnosis of AR-PCNSL had a sensitivity of 100.0%, and a specificity of 60.0%. The sensitivity and specificity of the conventional MR sequence combined with the SWI-ITSS sequence in the diagnosis of AR-PCNSL were 100 and 70.0%. The conventional MR combined with ADC or SWI-ITSS improved the diagnosis of AR-PCNSL.

Conclusion

Multimodal MR could distinguish AR-PCNSL from infectious lesions. The multimodal MR (DWI/ADC or SWI-ITSS) combined with conventional MR could improve the diagnosis of AR-PCNSL. The ADC value should be attached importance in clinical work. When distinguishing AR-PCNSL from toxoplasmosis or tuberculoma, SWI should be used to obtain a correct diagnosis.
Literature
1.
go back to reference Offiah CE, Turnbull IW. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol. 2006;61:393–401.CrossRef Offiah CE, Turnbull IW. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol. 2006;61:393–401.CrossRef
2.
go back to reference Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. HIV/AIDS Cancer Match Study AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99:962–72.CrossRef Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. HIV/AIDS Cancer Match Study AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99:962–72.CrossRef
3.
go back to reference Agrawal D, Hussain N. Decompressive craniectomy in cerebral toxoplasmosis. Eur J Clin Microbiol Infect Dis. 2005;24:772–3.CrossRef Agrawal D, Hussain N. Decompressive craniectomy in cerebral toxoplasmosis. Eur J Clin Microbiol Infect Dis. 2005;24:772–3.CrossRef
4.
go back to reference Lee SB, Lee TG. Toxoplasmic encephalitis in patient with acquired immunodeficiency syndrome. Brain Tumor Res Treat. 2017;5:34–6.CrossRef Lee SB, Lee TG. Toxoplasmic encephalitis in patient with acquired immunodeficiency syndrome. Brain Tumor Res Treat. 2017;5:34–6.CrossRef
5.
go back to reference Lai RP, Meintjes G, Wilkinson RJ. HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome. Semin Immunopathol. 2016;38:185–98.CrossRef Lai RP, Meintjes G, Wilkinson RJ. HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome. Semin Immunopathol. 2016;38:185–98.CrossRef
6.
go back to reference Xue M, Xie R, Pang Y, et al. Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China. BMC Infect Dis. 2020;20:554.CrossRef Xue M, Xie R, Pang Y, et al. Prevalence and risk factors of paradoxical tuberculosis associated immune reconstitution inflammatory syndrome among HIV-infected patients in Beijing, China. BMC Infect Dis. 2020;20:554.CrossRef
7.
go back to reference Khanna N, Elzi L, Mueller NJ, et al. Swiss HIV cohort study. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV cohort study. Clin Infect Dis. 2009;48:1459–66.CrossRef Khanna N, Elzi L, Mueller NJ, et al. Swiss HIV cohort study. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV cohort study. Clin Infect Dis. 2009;48:1459–66.CrossRef
8.
go back to reference Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nat Rev Neurol. 2016;12:662–74.CrossRef Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nat Rev Neurol. 2016;12:662–74.CrossRef
9.
go back to reference Kasamon YL, Ambinder RF. AIDS-related primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2005;19:665–87.CrossRef Kasamon YL, Ambinder RF. AIDS-related primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2005;19:665–87.CrossRef
10.
go back to reference Ernst TM, Chang L, Witt MD, et al. Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients. Radiology. 1998;208:663–9.CrossRef Ernst TM, Chang L, Witt MD, et al. Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients. Radiology. 1998;208:663–9.CrossRef
11.
go back to reference Hoang-Xuan K, Bessell E, Bromberg J, et al. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 2015;16:e322–32.CrossRef Hoang-Xuan K, Bessell E, Bromberg J, et al. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 2015;16:e322–32.CrossRef
12.
go back to reference Suh CH, Kim HS, Jung SC, Park JE, Choi CG, Kim SJ. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: a systematic review and meta-analysis. J Magn Reson Imaging. 2019;50:560–72.CrossRef Suh CH, Kim HS, Jung SC, Park JE, Choi CG, Kim SJ. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: a systematic review and meta-analysis. J Magn Reson Imaging. 2019;50:560–72.CrossRef
13.
go back to reference Ding Y, Xing Z, Liu B, Lin X, Cao D. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging. Brain Behav. 2014;4:841–9.CrossRef Ding Y, Xing Z, Liu B, Lin X, Cao D. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging. Brain Behav. 2014;4:841–9.CrossRef
14.
go back to reference Dibble EH, Boxerman JL, Baird GL, Donahue JE, Rogg JM. Toxoplasmosis versus lymphoma: cerebral lesion characterization using DSC-MRI revisited. Clin Neurol Neurosurg. 2017;152:84–9.CrossRef Dibble EH, Boxerman JL, Baird GL, Donahue JE, Rogg JM. Toxoplasmosis versus lymphoma: cerebral lesion characterization using DSC-MRI revisited. Clin Neurol Neurosurg. 2017;152:84–9.CrossRef
15.
go back to reference Thurnher MM, Boban J, Rieger A, Gelpi E. Susceptibility-weighted MR imaging Hypointense rim in progressive multifocal Leukoencephalopathy: the end point of Neuroinflammation and a potential outcome predictor. AJNR am J Neuroradiol. 2019;40:994–1000.CrossRef Thurnher MM, Boban J, Rieger A, Gelpi E. Susceptibility-weighted MR imaging Hypointense rim in progressive multifocal Leukoencephalopathy: the end point of Neuroinflammation and a potential outcome predictor. AJNR am J Neuroradiol. 2019;40:994–1000.CrossRef
16.
go back to reference Sun JJ, Lu HZ. Highlights of the third edition of Chinese guidelines for AIDS diagnosis and treatment(2015). Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015;44:597–602. Sun JJ, Lu HZ. Highlights of the third edition of Chinese guidelines for AIDS diagnosis and treatment(2015). Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015;44:597–602.
17.
go back to reference Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol. 2009;30:1402–8.CrossRef Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol. 2009;30:1402–8.CrossRef
18.
go back to reference Vivithanaporn P, Heo G, Gamble J, et al. Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology. 2010;75:1150–8.CrossRef Vivithanaporn P, Heo G, Gamble J, et al. Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology. 2010;75:1150–8.CrossRef
19.
go back to reference Bilgrami M, O'Keefe P. Neurologic diseases in HIV-infected patients. Handb Clin Neurol. 2014;121:1321–44.CrossRef Bilgrami M, O'Keefe P. Neurologic diseases in HIV-infected patients. Handb Clin Neurol. 2014;121:1321–44.CrossRef
20.
go back to reference Ota Y, Hishima T, Mochizuki M, et al. Classification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition. Cancer Med. 2014;3:143–53.CrossRef Ota Y, Hishima T, Mochizuki M, et al. Classification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition. Cancer Med. 2014;3:143–53.CrossRef
21.
go back to reference Engels EA, Pfeiffer RM, Goedert JJ, et al. HIV/AIDS Cancer match study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20:1645–54.CrossRef Engels EA, Pfeiffer RM, Goedert JJ, et al. HIV/AIDS Cancer match study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006;20:1645–54.CrossRef
22.
go back to reference Sparano JA, Lee JY, Kaplan LD, et al. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 2010;115:3008–16.CrossRef Sparano JA, Lee JY, Kaplan LD, et al. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 2010;115:3008–16.CrossRef
23.
go back to reference Chen H, Lin F, Liu S, Da Y, Guo D. Neurological manifestations, laboratory and neuroimaging features in HIV-infected patients. Neurosciences (Riyadh). 2017;22:311–5.CrossRef Chen H, Lin F, Liu S, Da Y, Guo D. Neurological manifestations, laboratory and neuroimaging features in HIV-infected patients. Neurosciences (Riyadh). 2017;22:311–5.CrossRef
24.
go back to reference Matinella A, Lanzafame M, Bonometti MA, et al. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study. J Neurol. 2015;262:1317–27.CrossRef Matinella A, Lanzafame M, Bonometti MA, et al. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study. J Neurol. 2015;262:1317–27.CrossRef
25.
go back to reference Hamdeh S, Abbas A, Fraker J, Lambrecht JE. Intracranial toxoplasmosis presenting as panhypopituitarism in an immunocompromised patient. Am J Emerg Med. 2015;33:1841–8.CrossRef Hamdeh S, Abbas A, Fraker J, Lambrecht JE. Intracranial toxoplasmosis presenting as panhypopituitarism in an immunocompromised patient. Am J Emerg Med. 2015;33:1841–8.CrossRef
26.
go back to reference Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15:211–22.CrossRef Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15:211–22.CrossRef
27.
go back to reference Bhagavati S, Choi J. Frequent hemorrhagic lesions in cerebral toxoplasmosis in AIDS patients. J Neuroimaging. 2009;19:169–73.CrossRef Bhagavati S, Choi J. Frequent hemorrhagic lesions in cerebral toxoplasmosis in AIDS patients. J Neuroimaging. 2009;19:169–73.CrossRef
28.
go back to reference Sudhakar P, Bachman DM, Mark AS, Berger JR, Kedar S. Progressive multifocal Leukoencephalopathy: recent advances and a Neuro-ophthalmological review. J Neuroophthalmol. 2015;35:296–305.CrossRef Sudhakar P, Bachman DM, Mark AS, Berger JR, Kedar S. Progressive multifocal Leukoencephalopathy: recent advances and a Neuro-ophthalmological review. J Neuroophthalmol. 2015;35:296–305.CrossRef
29.
go back to reference Corti M, Villafañe M, Trione N, Yampolsky C, Sevlever G. Progressive multifocal leukoencephalopathy presenting as IRIS in an AIDS patient. A case report and literature review. Neuroradiol J. 2013;26:151–4.CrossRef Corti M, Villafañe M, Trione N, Yampolsky C, Sevlever G. Progressive multifocal leukoencephalopathy presenting as IRIS in an AIDS patient. A case report and literature review. Neuroradiol J. 2013;26:151–4.CrossRef
30.
go back to reference Mader I, Herrlinger U, Klose U, Schmidt F, Küker W. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology. 2003;45:717–21.CrossRef Mader I, Herrlinger U, Klose U, Schmidt F, Küker W. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI. Neuroradiology. 2003;45:717–21.CrossRef
31.
go back to reference Sainz-de-la-Maza S, Casado JL, Pérez-Elías MJ, et al. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy. Eur J Neurol. 2016;23:919–25.CrossRef Sainz-de-la-Maza S, Casado JL, Pérez-Elías MJ, et al. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy. Eur J Neurol. 2016;23:919–25.CrossRef
32.
go back to reference Camacho DL, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. AJNR Am J Neuroradiol. 2003;24:633–7.PubMed Camacho DL, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. AJNR Am J Neuroradiol. 2003;24:633–7.PubMed
33.
go back to reference You SH, Yun TJ, Choi HJ, et al. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging. Eur Radiol. 2018;28:3801–10.CrossRef You SH, Yun TJ, Choi HJ, et al. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging. Eur Radiol. 2018;28:3801–10.CrossRef
34.
go back to reference Lai PH, Chung HW, Chang HC, et al. Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors. Eur J Radiol. 2019;117:56–61.CrossRef Lai PH, Chung HW, Chang HC, et al. Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors. Eur J Radiol. 2019;117:56–61.CrossRef
35.
go back to reference Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med. 2008;60:1488–97.CrossRef Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med. 2008;60:1488–97.CrossRef
36.
go back to reference da Rocha AJ, Sobreira Guedes BV, da Silveira da Rocha TM, Maia Junior AC, Chiattone CS. Modern techniques of magnetic resonance in the evaluation of primary central nervous system lymphoma: contributions to the diagnosis and differential diagnosis. Rev Bras Hematol Hemoter. 2016;38:44–54.CrossRef da Rocha AJ, Sobreira Guedes BV, da Silveira da Rocha TM, Maia Junior AC, Chiattone CS. Modern techniques of magnetic resonance in the evaluation of primary central nervous system lymphoma: contributions to the diagnosis and differential diagnosis. Rev Bras Hematol Hemoter. 2016;38:44–54.CrossRef
37.
go back to reference Simone IL, Federico F, Tortorella C, et al. 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry. 1998;64:516–23.CrossRef Simone IL, Federico F, Tortorella C, et al. 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry. 1998;64:516–23.CrossRef
38.
go back to reference Haubold J, Demircioglu A, Gratz M, et al. Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR fingerprinting. Eur J Nucl Med Mol Imaging. 2020;47:1435–45.CrossRef Haubold J, Demircioglu A, Gratz M, et al. Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR fingerprinting. Eur J Nucl Med Mol Imaging. 2020;47:1435–45.CrossRef
39.
go back to reference Song L, Zhang W, Chen H, et al. Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression. Int J Nanomedicine. 2019;14:921–36.CrossRef Song L, Zhang W, Chen H, et al. Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression. Int J Nanomedicine. 2019;14:921–36.CrossRef
Metadata
Title
A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection
Authors
Jingjing Li
Ming Xue
Shuo Yan
Chunshuang Guan
Ruming Xie
Budong Chen
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2021
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-05779-4

Other articles of this Issue 1/2021

BMC Infectious Diseases 1/2021 Go to the issue